Cargando…
C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer
The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl transferases). It is likely that malfunction of this enzymatic machinery controlling epigenetic modification is relevant to carcinogenesis and tumor progre...
Autores principales: | Ono, Hiroaki, Kato, Tomotaka, Murase, Yoshiki, Nakamura, Yutaro, Ishikawa, Yoshiya, Watanabe, Shuichi, Akahoshi, Keiichi, Ogura, Toshiro, Ogawa, Kosuke, Ban, Daisuke, Kudo, Atsushi, Akiyama, Yoshimitsu, Tanaka, Shinji, Ito, Hiromichi, Tanabe, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115044/ https://www.ncbi.nlm.nih.gov/pubmed/33980911 http://dx.doi.org/10.1038/s41598-021-89530-8 |
Ejemplares similares
-
RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer
por: Ono, Hiroaki, et al.
Publicado: (2023) -
Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconstruction using saphenous vein grafting for locally advanced pancreatic cancer: a case report
por: Murase, Yoshiki, et al.
Publicado: (2020) -
Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers
por: Murase, Yoshiki, et al.
Publicado: (2021) -
Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells
por: Kato, Tomotaka, et al.
Publicado: (2021) -
Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms
por: Murase, Yoshiki, et al.
Publicado: (2021)